Lamotrigine and valproate: Efficacy of co-administration in a pediatric population

Pediatric Neurology

Volumn 28, Issue 5, 2003, Pages 360-364

  Thomé Souza, Sigride ^a   Freitas, Alessandra ^a   Fiore, Lia A ^a   Valente, Kette D ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Lab of Clinical Neurophysiology   (Brazil)

Author keywords

Children; Co administration; Epilepsy; Lamotrigine; Valproate

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CORTICOTROPIN; ETHOSUXIMIDE; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOPIA; DISEASE CONTROL; DOSE RESPONSE; DROP ATTACK; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; EVALUATION; FEMALE; HUMAN; KETOGENIC DIET; MALE; MENTAL DISEASE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; RASH; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; URINE INCONTINENCE; VERTIGO; WEIGHT GAIN;

EID: 0038376462     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00014-6     Document Type: Article

References (21)

1. Cramer J.A., Fisher R., Bem-Menachem E., French J., Mattson R.H. New antiepileptic drug Comparison of key clinical trials . Epilepsia. 40:1999;590-600.
2. Panayiotopoulos C.P., Ferrie C.D., Knott C., Robinson R.O. Interaction of lamotrigine with sodium valproate. Lancet. 341:1993;445. [Letter].
3. Pisani F., Russo M., Trio R. Efficacia dell'associazione lamotrigina-valproato di sódio nelle crisi epilettiche parziali resistenti. Q Acta Neurol. 58:1992;71-73.
4. Pisani F., Di Perri R., Perucca E., Richens A. Interaction of lamotrigine with sodium valproate. Lancet. 341:1993;1224. [Comment Letter].
5. Brodie M.J., Yuen A.W.C. Lamotrigine substitution study Evidence for synergism with sodium valproate . Epilepsy Res. 26:1997;423-432.
6. Yuen A.W.C., Land G., Wetherley B.C., Peck A.W. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol. 33:1992;511-513.
7. Morris R.G., Black A.B., Lam E., Westley I.S. Clinical study of lamotrigine and valproic acid in patients with epilepsy Using a drug interation to advantage? Therapeutic Drug Monitor. 22:2000;656-660.
8. Kanner A.M., Frey M. Adding valproate to lamotrigine A study of their pharmacokinetic interaction . Neurology. 55:2000;588-591.
9. Pisani F., Oteri G., Russo M.F., Di Perri R., Perucca E., Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures Evidence for a pharmacodynamic interaction . Clin Res. 40:1999;1141-1146.
10. Guberman A.H., Besag F.M.C., Brodie M.J. Lamotrigine-associated rash: Risk/benefit considerations in adults and children. Epilepsia. 40:1999;985-991.
11. Duchowny M., Pellock J.M., Graf W.D. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology. 53:1999;1724-1731.
12. McCabe P.H., Michel N.C., McNew C.D. Clinical efficacy of combination therapy with valproic acid and lamotrigine in intractable epilepsy. Epilepsia. 39:(Suppl 6):1998;49.
13. Ferrie C.D., Robinson R.O., Knott C., Panayiotopoulos C.P. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand. 91:1995;200-202.
14. McCabe P.H., McNew C.D., Michel N.C. Effect of divalproex-lamotrigine combination therapy in frontal lobe seizures. Arch Neurol. 58:2000;1264-1268.
15. Ramaratnam S., Marson A.G., Baker G.A. Lamotrigine add-on for drug-resistant epilepsy. Cochrane Database Syst Rev. 3:2000;CD001909.
16. Messenheimer J.A., Giorgi L., Risner M.E. The tolerability of lamotrigine in children. Drug Safety. 22:2000;303-312.
17. Besag F.M.C. Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research. 42:(Suppl 1):1998;50-56.
18. Biton V., Mirza W., Montouris G., Vuong A., Hammer A.E., Barret P.S. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 56:2001;172-177.
19. Ettinger A.B., Weisbrot D.M., Saracco J., Dhoon A., Kanner A., Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia. 39:1998;874-877.
20. Gidal B.E., Anderson G.D., Rutecki P.R., Shaw R., Lanning A. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epil Res. 42:2000;23-31.
21. Matsuo F. Lamotrigine. Epilepsia. 40:(Suppl. 5):1999;S30-S36.